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Overview
Advances in high-throughput sequencing, genotyping,
and characterization of haplotype diversity are consis-
tently generating vast amounts of genomic data. Single
Nucleotide Polymorphisms (SNPs) are the most common
type of genetic variation [1]. In the recent years the num-
ber of known SNPs has been increasing exponentially [2];
the last release of the NCBI’s dbSNP database [3] con-
tained more than 55 million human SNPs. SNPs are
interesting as both markers of evolutionary history and in
the context of their phenotypic manifestations (e.g. char-
acteristic traits and diseases). However, due to their sheer
number, detailed experimental annotations are impossi-
ble and computational inference is severely limited by the
required resources. SNPs also present a challenge for
visualization and storage.
In line with the increasing interest in the genetic varia-
tion analysis and annotation, on July 14th, 2012 [4] we
organized the second SNP Special Interesting Group
(SNP-SIG) meeting at the ISMB’12 in Long Beach, CA.
This meeting attempted to summarize the field’s research
advances in the directions of “Annotation and prediction
of structural/functional impacts of coding SNPs” and
“SNPs and Personal Genomics: GWAS, populations and
phylogenetic analysis”. The discrepancy between the sig-
nificant availability of the SNP data and the current lack of
its interpretation requires the development of new compu-
tational annotation methods. The analysis of genetic varia-
tion is a key factor for the understanding of the genomic
information. The SNP-SIG provides a forum necessary for
the organization of a research network facilitating the
exchange of ideas and for the establishment of new
collaborations to manage the complexity of the analysis of
genetic variation. The one-day SIG attracted over 80 parti-
cipants, with nine “bleeding-edge” research talks and five
presentations from the leading scientists in the field.
The topics covered in the SIG presentations focused
primarily on annotating the phenotypic traits associated
with the specific SNPs - everything from annotating asso-
ciated protein function changes [5-10] to screening phar-
mocogenomic variants [11] to finding driver mutations in
cancer [12,13]. There was also some focus on improving
method performance, e.g. a new way to efficiently analyze
multi-GWAS data [14]. Finally, the issues of the quality
of the current experimental variant annotations were also
discussed. While the overall focus of the SIG was clearly
on the side of improving variant annotation accuracy, the
participants clearly recognized the need for faster meth-
ods capable of dealing with larger sets and noisy data.
Although recognized as existing issues, the visualization
of the SNP data and increasing data storage concerns,
were not explicitly addressed. These will be a stressed
focus in the future SNP-SIG meetings.
Next meeting
We are currently preparing for the next edition of the
SNP-SIG meeting to be held in the context of the ISMB
2013, Berlin, Germany. Further information about the
SNP-SIG 2013 is available on our web site (http://snpsig.
biofold.org).
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